| Ataxia rating scales—psychometric profiles, natural history and their application in clinical trials JAM Saute, KC Donis, C Serrano-Munuera, D Genis, LT Ramirez, ... The Cerebellum 11, 488-504, 2012 | 153 | 2012 |
| Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial L Schöls, TW Rattay, P Martus, C Meisner, J Baets, I Fischer, C Jägle, ... Brain 140 (12), 3112-3127, 2017 | 106 | 2017 |
| Survival estimates for patients with Machado–Joseph disease (SCA3) C Kieling, PR Prestes, ML Saraiva‐Pereira, LB Jardim Clinical genetics 72 (6), 543-545, 2007 | 104 | 2007 |
| Nonmotor and extracerebellar features in Machado‐Joseph disease: a review JL Pedroso, MC Franca Jr, P Braga‐Neto, A D'Abreu, ML Saraiva‐Pereira, ... Movement Disorders 28 (9), 1200-1208, 2013 | 103 | 2013 |
| Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson´ s disease EF Dos Santos, ENB Busanello, A Miglioranza, Â Zanatta, AG Barchak, ... Metabolic brain disease 24, 257-269, 2009 | 93 | 2009 |
| Interleukin-6 serum levels in patients with Parkinson’s disease KW Hofmann, AFS Schuh, J Saute, R Townsend, D Fricke, R Leke, ... Neurochemical research 34, 1401-1404, 2009 | 92 | 2009 |
| A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3) C Kieling, CRM Rieder, ACF Silva, JAM Saute, CR Cecchin, TL Monte, ... European journal of neurology 15 (4), 371-376, 2008 | 85 | 2008 |
| A randomized, phase 2 clinical trial of lithium carbonate in Machado‐Joseph disease JAM Saute, RM de Castilhos, TL Monte, AF Schumacher‐Schuh, ... Movement Disorders 29 (4), 568-573, 2014 | 80 | 2014 |
| A systematic review and evidence-based guideline for diagnosis and treatment of Menkes disease FP e Vairo, BC Chwal, S Perini, MAP Ferreira, AC de Freitas Lopes, ... Molecular genetics and metabolism 126 (1), 6-13, 2019 | 78 | 2019 |
| Machado Joseph disease: clinical and genetic aspects, and current treatment JAM Saute, LB Jardim Expert Opinion on Orphan Drugs 3 (5), 517-535, 2015 | 63 | 2015 |
| Progression rate of neurological deficits in a 10-year cohort of SCA3 patients LB Jardim, L Hauser, C Kieling, JAM Saute, R Xavier, CRM Rieder, ... The Cerebellum 9, 419-428, 2010 | 60 | 2010 |
| Effects of depressive-like behavior of rats on brain glutamate uptake RF Almeida, AP Thomazi, GF Godinho, JAM Saute, ST Wofchuk, ... Neurochemical research 35, 1164-1171, 2010 | 57 | 2010 |
| Body mass index is inversely correlated with the expanded CAG repeat length in SCA3/MJD patients JAM Saute, ACF da Silva, GN Souza, AD Russo, KC Donis, L Vedolin, ... The Cerebellum 11, 771-774, 2012 | 53 | 2012 |
| Peripheral oxidative stress biomarkers in spinocerebellar ataxia type 3/Machado–Joseph disease AM de Assis, JAM Saute, A Longoni, CB Haas, VR Torrez, AW Brochier, ... Frontiers in neurology 8, 485, 2017 | 50 | 2017 |
| Clinical and molecular characterization of hereditary spastic paraplegias: a next-generation sequencing panel approach D Burguez, M Polese-Bonatto, LAJ Scudeiro, I Björkhem, L Schöls, ... Journal of the Neurological Sciences 383, 18-25, 2017 | 49 | 2017 |
| Occupational therapy in spinocerebellar ataxia type 3: an open-label trial RCR Silva, JAM Saute, ACF Silva, ACO Coutinho, ML Saraiva-Pereira, ... Brazilian Journal of Medical and Biological Research 43, 537-542, 2010 | 48 | 2010 |
| Spinocerebellar ataxia type 3/Machado–Joseph disease: segregation patterns and factors influencing instability of expanded CAG transmissions GN Souza, N Kersting, AC Krum‐Santos, ASP Santos, GV Furtado, ... Clinical genetics 90 (2), 134-140, 2016 | 47 | 2016 |
| Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNS R Giugliani, F Vairo, F Kubaski, F Poswar, M Riegel, G Baldo, JA Saute The Lancet Child & Adolescent Health 2 (1), 56-68, 2018 | 45 | 2018 |
| Serum insulin‐like system alterations in patients with spinocerebellar ataxia type 3 JAM Saute, ACF da Silva, AP Muller, G Hansel, AS de Mello, F Maeda, ... Movement Disorders 26 (4), 731-735, 2011 | 42 | 2011 |
| Amnesic effect of GMP depends on its conversion to guanosine JAM Saute, LE da Silveira, FA Soares, LH Martini, DO Souza, M Ganzella Neurobiology of learning and memory 85 (3), 206-212, 2006 | 41 | 2006 |
